GLP-1 receptor agonists are transforming obesity treatment
a indicates the map threshold
Some patients may experience improvements in cholesterol and other metabolic markers while taking semaglutide, although results vary significantly from person to person
Pair with nutrition, hydration, and daily movement
Contact us today at [email protected] for detailed product specifications, competitive pricing, and technical consultation
Patients should contact their GP if they experience significant deterioration in blood glucose control (persistent readings above 15 mmol/L, symptoms of hyperglycaemia such as excessive thirst or urination), unexplained weight changes, or any concerning symptoms after stopping treatment